JPH0456626B2 - - Google Patents

Info

Publication number
JPH0456626B2
JPH0456626B2 JP58176417A JP17641783A JPH0456626B2 JP H0456626 B2 JPH0456626 B2 JP H0456626B2 JP 58176417 A JP58176417 A JP 58176417A JP 17641783 A JP17641783 A JP 17641783A JP H0456626 B2 JPH0456626 B2 JP H0456626B2
Authority
JP
Japan
Prior art keywords
container
carbon dioxide
internal pressure
space
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58176417A
Other languages
Japanese (ja)
Other versions
JPS6068856A (en
Inventor
Katsuzo Ida
Yoshio Kogure
Tomio Onda
Yukishige Matsumura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to JP58176417A priority Critical patent/JPS6068856A/en
Publication of JPS6068856A publication Critical patent/JPS6068856A/en
Publication of JPH0456626B2 publication Critical patent/JPH0456626B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は容器内圧の増加防止方法に関する。 鼻腔洗浄剤、膣洗浄剤、口腔吸入剤等の医薬用
水溶液あるいは酪農専用清毒剤等の動物薬用水溶
液に炭酸水素ナトリウムが配合される機会は多
い。特に殺菌消毒を目的として陽イオン性界面活
性剤、すなわち逆性石ケンを配合した水溶液にお
いては炭酸水素ナトリウムが主として配される。
炭酸水素ナトリウムは水溶液のPHを生理的PHに緩
衝する上で特に便利なのである。緩衝剤としては
ポリリン酸ナトリウム、トリポリリン酸ナトリウ
ムなどのリン酸系化合物あるいは、硅酸塩類、ク
エン酸ナトリウム、グリコン酸ナトリウム等があ
るが、リン酸系化合物は水質汚染が起こりやす
く、硅酸塩類は溶解性が低く、グルコン酸ナトリ
ウム、クエン酸ナトリウムは経時的に変色するほ
か、希釈した場合における緩衝能が劣つている等
の理由により、使用されないかあるいは使用され
ても実用的ではない。炭酸水素ナトリウムはこう
した難点を持たないので、上記医薬用あるいは動
物薬用の水溶液に実用的に、かつ便利に使用され
る。 しかしながら、炭酸ナトリウム水溶液が加温に
より二酸化炭素ガスを発生することはよく知られ
るところであり、従つて、炭酸水素ナトリウムが
配合された水溶液を容器に充填密閉した場合にお
いて、容器が外部より加温されたときには、発生
した二酸化炭素ガスにより容器内圧が増加する危
険がある。例えば圧力により変形しやすいプラス
チツク容器においては内圧増加により膨張、変
形、破損の危険があり、またガラス容器、ブリキ
容器においては内圧増加により開封時に内容液が
飛沫する危険がある。 本発明者はこの危険を解消するために炭酸水素
ナトリウムが配合された水溶液を充填した容器の
容器内圧の増加を防止することを目的として検討
をおこない、その結果、容器空間の一部を二酸化
炭素ガスによつて置換することにより、該目的が
達成されることを知り本発明を完成した。 本発明を説明する。 炭酸水素ナトリウムおよび二酸化炭素ガス(炭
酸ガス)はそれぞれ市販のものを使用すればよ
い。二酸化炭素ガスが容器空間を占める置換率は
大きい程有効であり、特に限定はされないが、後
記実験例に示されるとおり、40%に達すると内圧
は無視できるほどに小さくなり、40%以上である
必要はなくなる。 炭酸水素ナトリウムの濃度は水溶液の用途およ
び必要な緩衝能に応じて自由に適宜定められ、本
発明を限定するものではない。 本発明に係る水溶液は医薬用、動物薬用であ
り、特に殺菌消毒の目的で陽イオン性界面活性剤
が配合される場合に有効であるが、これに限定さ
れない。また本発明に係る容器は医薬用、動物薬
用の水溶液が充填される容器一般であり、特にプ
ラスチツク容器の場合に有効であるが、これに限
定されない。 まず所定容器に本発明に係る水溶液を充填し、
次に二酸化炭素ガスを空間部分に注入し、直ちに
密閉すればよい。 次に本発明の効果を実験例をもつて説明する。 実験例 1 3%炭酸水素ナトリウム水溶液400mlを内容積
700mlバイアル瓶へ充填し、その空間を炭酸ガス
濃度5%、10%、15%、20%、25%、30%、35
%、40%になる様に炭酸ガス置換した後、ゴム栓
打栓、アルミキヤツプ捲締した。これを45℃恒温
室にて10日間保存した後、圧力ゲージでバイアル
空間の圧力を測定しその結果を第1表に示した。
The present invention relates to a method for preventing an increase in container internal pressure. Sodium bicarbonate is often blended into medicinal aqueous solutions such as nasal washes, vaginal washes, and oral inhalants, or animal medicinal aqueous solutions such as dairy disinfectants. In particular, in an aqueous solution containing a cationic surfactant, that is, an inverse soap, for the purpose of sterilization, sodium hydrogen carbonate is mainly used.
Sodium bicarbonate is particularly useful in buffering the pH of aqueous solutions to physiological pH. Buffers include phosphate compounds such as sodium polyphosphate and sodium tripolyphosphate, silicates, sodium citrate, and sodium glyconate, but phosphate compounds tend to cause water pollution, and silicates are Sodium gluconate and sodium citrate have low solubility, change color over time, and have poor buffering capacity when diluted, so they are not used or are not practical even if they are used. Sodium bicarbonate does not have these drawbacks, and is therefore practically and conveniently used in the above-mentioned aqueous solutions for pharmaceuticals or veterinary medicines. However, it is well known that an aqueous sodium carbonate solution generates carbon dioxide gas when heated. Therefore, when a container is filled with an aqueous solution containing sodium bicarbonate and sealed, the container is not heated from the outside. When this occurs, there is a risk that the internal pressure of the container will increase due to the generated carbon dioxide gas. For example, plastic containers that are easily deformed by pressure are at risk of expansion, deformation, and breakage due to increased internal pressure, while glass and tin containers are at risk of being splashed by the liquid content when opened due to increased internal pressure. In order to eliminate this danger, the present inventor conducted a study with the aim of preventing an increase in the internal pressure of a container filled with an aqueous solution containing sodium bicarbonate, and as a result, a part of the container space was filled with carbon dioxide. The present invention was completed based on the knowledge that the objective can be achieved by replacing the gas with a gas. The present invention will be explained. Commercially available sodium bicarbonate and carbon dioxide gas may be used. The larger the replacement rate at which carbon dioxide gas occupies the container space, the more effective it is, and although it is not particularly limited, as shown in the experimental example below, when it reaches 40%, the internal pressure becomes negligible, and it is 40% or more. There will be no need. The concentration of sodium hydrogen carbonate can be freely determined as appropriate depending on the use of the aqueous solution and the required buffering capacity, and does not limit the present invention. The aqueous solution according to the present invention is used for medicine and veterinary medicine, and is particularly effective when a cationic surfactant is added for the purpose of sterilization, but the solution is not limited thereto. Further, the container according to the present invention is a general container filled with an aqueous solution for medicine or veterinary medicine, and is particularly effective in the case of a plastic container, but is not limited thereto. First, a predetermined container is filled with the aqueous solution according to the present invention,
Next, carbon dioxide gas may be injected into the space and immediately sealed. Next, the effects of the present invention will be explained using experimental examples. Experimental example 1 400ml of 3% sodium bicarbonate aqueous solution
Fill a 700ml vial and fill the space with carbon dioxide concentration of 5%, 10%, 15%, 20%, 25%, 30%, 35
After replacing the carbon dioxide gas to a concentration of 40%, the bottle was sealed with a rubber stopper and rolled up with an aluminum cap. After storing this in a constant temperature room at 45°C for 10 days, the pressure in the vial space was measured using a pressure gauge, and the results are shown in Table 1.

【表】【table】

【表】 実験例 2 実験例1の炭酸水素ナトリウム含有水溶液を全
容量23の高密度ポリエチレン容器(最低肉厚
1.5mm以上、重量1.5Kg以上)に18充填し、その
空間を炭酸ガス濃度、15%、20%、25%、30%に
なる様に置換した。 これを45℃の恒温室にて10日間保存した後、容
器の縦および横の長さ、すなわち図1に示される
AおよびBの長さをパスで測定し、膨張増加した
長さを求めて第2表に示した。
[Table] Experimental Example 2 The sodium bicarbonate-containing aqueous solution of Experimental Example 1 was placed in a high-density polyethylene container with a total capacity of 23 mm (minimum wall thickness).
(1.5mm or more, weight 1.5Kg or more) was filled with 18 carbon dioxide gases, and the space was replaced with carbon dioxide gas concentration of 15%, 20%, 25%, and 30%. After storing this in a constant temperature room at 45℃ for 10 days, the vertical and horizontal lengths of the container, that is, the lengths of A and B shown in Figure 1, were measured using passes, and the increased length due to expansion was determined. It is shown in Table 2.

【表】 以下に記載する実施例をもつて本発明をさらに
具体的に説明する。 実施例 1 メチルドデシルベンチルトリメチルアンモニウム
クロライドとメチルドデシルキシリレンビストリ
メチルアンモニウムクロライドの混合物 20部 ポリオキシエチレンオクチルフエニールエーテル
10部 炭酸水素ナトリウム 25部 を精製水にて溶解し全量23のポリエチレン容器
に18充填し、その空間を炭酸ガスで30%置換す
る。 実施例 2 ジメチルベンジルアルキルアンモニウムクロライ
ド(アルキルは炭素数8〜18) 10部 炭酸水素ナトリウム 30部 精製水にて溶解し全量23のポリエチレン容器
に18充填し、その空間を炭酸ガスで20%置換す
る。
[Table] The present invention will be explained in more detail with reference to the following examples. Example 1 Mixture of methyldodecylbentyltrimethylammonium chloride and methyldodecylxylylene bistrimethylammonium chloride 20 parts polyoxyethylene octyl phenyl ether
Dissolve 10 parts and 25 parts of sodium bicarbonate in purified water, fill 18 polyethylene containers with a total volume of 23, and replace 30% of the space with carbon dioxide gas. Example 2 Dimethylbenzylalkylammonium chloride (alkyl has 8 to 18 carbon atoms) 10 parts Sodium hydrogen carbonate 30 parts Dissolve in purified water, fill 18 polyethylene containers with a total volume of 23, and replace 20% of the space with carbon dioxide gas .

【図面の簡単な説明】[Brief explanation of the drawing]

図1は実験例2に記載の図1に相当し、高密度
ポリエチレン容器の上面図を表わす図面である。
FIG. 1 corresponds to FIG. 1 described in Experimental Example 2 and is a drawing showing a top view of a high-density polyethylene container.

Claims (1)

【特許請求の範囲】 1 炭酸水素ナトリウムが配合された医薬用ある
いは動物薬用水溶液を容器に充填するにあたり、
当該容器の空間の一部を二酸化炭素によつて置換
することを特徴とする容器内圧の増加防止方法。 2 容器がプラスチツク容器である特許請求の範
囲第1項記載の容器内圧の増加防止方法。 3 空間の一部が5〜40%である特許請求の範囲
第1項または第2項記載の容器内圧の増加防止方
法。
[Claims] 1. When filling a container with a pharmaceutical or veterinary aqueous solution containing sodium bicarbonate,
A method for preventing an increase in internal pressure of a container, characterized by replacing a part of the space in the container with carbon dioxide. 2. The method for preventing an increase in internal pressure of a container according to claim 1, wherein the container is a plastic container. 3. The method for preventing an increase in internal pressure of a container according to claim 1 or 2, wherein a portion of the space is 5 to 40%.
JP58176417A 1983-09-26 1983-09-26 Prevention of increase in internal pressure of container Granted JPS6068856A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58176417A JPS6068856A (en) 1983-09-26 1983-09-26 Prevention of increase in internal pressure of container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58176417A JPS6068856A (en) 1983-09-26 1983-09-26 Prevention of increase in internal pressure of container

Publications (2)

Publication Number Publication Date
JPS6068856A JPS6068856A (en) 1985-04-19
JPH0456626B2 true JPH0456626B2 (en) 1992-09-09

Family

ID=16013324

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58176417A Granted JPS6068856A (en) 1983-09-26 1983-09-26 Prevention of increase in internal pressure of container

Country Status (1)

Country Link
JP (1) JPS6068856A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0632649B2 (en) * 1986-02-20 1994-05-02 ロ−ト製薬株式会社 Liquid pharmaceutical packaging
JP2505329B2 (en) * 1991-08-28 1996-06-05 扶桑薬品工業株式会社 Package for storing chemical solutions containing bicarbonate compounds
AU669773B2 (en) * 1993-01-22 1996-06-20 Otsuka Pharmaceutical Factory, Inc. Bicarbonate-containing powdered medicine storage container and method of stabilizing the same medicine
JP2527532B2 (en) * 1994-04-25 1996-08-28 扶桑薬品工業株式会社 New application of carbon dioxide generating oxygen absorber

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56166853A (en) * 1980-05-26 1981-12-22 Nikkiso Co Ltd Method of preserving and using bicarbonate undiluted solution
JPS5810058A (en) * 1981-07-10 1983-01-20 日機装株式会社 Dialytic liquid storage tank

Also Published As

Publication number Publication date
JPS6068856A (en) 1985-04-19

Similar Documents

Publication Publication Date Title
JP3060133U (en) Eye perfusion / wash bag package
JP2010515509A (en) Storage of ampoules containing pharmaceutical formulations using sealed containers containing oxygen scavengers
CL2021000290A1 (en) A method of obtaining the liquid dosage form of the drug edaravone, which is stable during storage, transportation and convenient use
JP2009248983A (en) Medicine tablet
JPH0456626B2 (en)
HRP20020636A2 (en) Pharmaceutical composition comprising pemetrexed with monothioglycerol l-cystein or thioglycolic acid
JP7541984B2 (en) Stable aqueous injection solutions of epinephrine
JP3636372B2 (en) Mesna injection solution, process for producing the same, and medicament for avoiding side effects of oxyazaphospholine comprising the same
US3857677A (en) Method of sterile packaging
JPS62194861A (en) Liquid drug package
US4073907A (en) Stabilized aminophylline solution and process therefor
JP2505329B2 (en) Package for storing chemical solutions containing bicarbonate compounds
US2213977A (en) Pharmaceutical
JP2750373B2 (en) Method for stabilizing aqueous pharmaceutical solution and container
CN208963570U (en) A kind of oil-based liquid dressing is protected from light and anti-fake inner packing device
US20120157496A1 (en) Stabilized and preserved ketotifen ophthalmic compositions
JPH0739596B2 (en) Liquid bleach composition
JP2527532B2 (en) New application of carbon dioxide generating oxygen absorber
CN115137700B (en) Dexmedetomidine aqueous solution preparation for reducing water loss rate
CN214969111U (en) Oral liquid medicine ration oral administration device of intracardiac patient
Yuldashev Stability and Product–Packaging Compatibility of ORS Formulations: A Comparative Study of Powder Barriers and the Case for Liquid Transition
UA132695U (en) A PULLE FILLED WITH A LIQUID DOSAGE FORM OF PARENTAL APPLICATION CONTAINING AN ACTIVE SUBSTANCE
HK40055546A (en) A stable aqueous injectable solution of epinephrine
CN203263810U (en) Sodium bicarbonate injection flexible package container
DeLuca et al. problems arising from the transfer of sodium bicarbonate injection from ampuls to plastic disposable syringes